Ein Arzt berät einen Patienten (Symbolbild).
Freitag, 31.05.2013 16:45 von | Aufrufe: 144

Fuse Science, Inc. CEO Interviewed by The Stock Radio

Ein Arzt berät einen Patienten (Symbolbild). © TommL / Vetta / Getty Images https://www.gettyimages.de/

PR Newswire

MIAMI LAKES, Fla., May 31, 2013 /PRNewswire/ -- Brian Tuffin, CEO of Fuse Science, Inc. (OTCQB: DROP) (www.fusescience.com), a consumer products and delivery technology company that is developing new, patent-pending technologies poised to redefine how consumers receive energy, medicines, vitamins and minerals was recently interviewed by The Stock Radio (www.thestockradio.com).  The Stock Radio, a small cap research and investment commentary provider in Europe, discussed with Mr. Tuffin the Company's business model, its growing distribution platform and licensing agenda, as well as the Fuse Science technology and core science applications.

The interview is available at: www.thestockradio.com   

About Fuse Science, Inc.
Fuse Science, Inc. (OTCQB: DROP), is an innovative consumer products and delivery technology company based in Miami Lakes, Florida.  Fuse Science holds the rights to new, patent-pending technologies poised to redefine how consumers receive energy, medicines, vitamins and minerals.  The Company maintains the rights to sublingual and transdermal delivery systems for bioactive agents that can now, for the first time, effectively encapsulate and charge many varying molecules in order to produce complete product formulations which can bypass the gastrointestinal tract and enter the blood stream directly - all in a concentrated "DROP" form that is simply applied under the tongue. 

The Fuse Science technology is designed to accelerate conveyance of medicines or nutrients relative to traditional pills and liquids and can enhance how consumers receive these products.  Information about Fuse Science is available online at www.fusescience.com and www.poweredbyfuse.com or by calling 305-503-FUSE (3873).

For Fuse news as it happens, follow @Fuse_Science on Twitter and Like Us on Facebook!

Get all Fuse Science corporate updates sent directly to you; sign up for Fuse News Alerts HERE.

For more information:


ARIVA.DE Börsen-Geflüster

Kurse

0,0139 $
-4,34%
Fuse Science Chart

To schedule an interview:


Fuse Science, Inc.

Gus DeQuesada


Investor Relations

Michelsen Advertising


Direct: (305) 503-3873, Ext. 2

C-305-733-1410 / 786-488-7138


Email: ir@fusescience.com

prnews@michelsenadvertising.com


About The Stock Radio
TheStockRadio is a small-cap research and investment commentary provider. TheStockRadio.com strives to provide a balanced view of many promising small-cap companies that would otherwise fall under the radar of the typical Wall Street investor. We provide investors with an excellent first step in their research and due diligence by providing daily trading ideas, and consolidating the public information available on them. For more information on TheStockRadio please visit http://thestockradio.com.

TheStockRadio.com Disclosure
TheStockRadio.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. TheStockRadio.com is a Web site wholly owned by Allan James Group.  TheStockRadio.com nor its affiliates have a beneficial interest in the mentioned company; nor have they received compensation of any kind for any of the companies listed in this communication. Please read our report and visit our Web site, TheStockRadio.com, for complete risks and disclosures.

SOURCE Fuse Science, Inc.

Werbung

Mehr Nachrichten zur Fuse Science Aktie kostenlos abonnieren

E-Mail-Adresse
Benachrichtigungen von ARIVA.DE
(Mit der Bestellung akzeptierst du die Datenschutzhinweise)

Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.


Andere Nutzer interessierten sich auch für folgende News